Technical analysis of Immunovant, Inc. (IMVT): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advancing novel monoclonal antibody therapies for the treatment of various autoimmune conditions. The company's primary focus is batoclimab, a pioneering, fully human monoclonal antibody. This antibody is engineered to specifically target and block the neonatal fragment crystallizable receptor (FcRn), a key mechanism in certain autoimmune diseases.
Price Performance
| 1 month | -15.50% |
| 3 months | -27.67% |
| Year-to-date | +11.76% |
| 1 year | +19.47% |
| 3 years | -16.42% |
| 5 years | +225.80% |
52-Week Range
| 52-week High | $45.42 |
| 52-week Low | $21.43 |
| Avg Volume (90d) | 1.3M |
Technical Indicators
| SMA 50 | $34.24 |
| SMA 200 | $32.05 |
| Beta | 0.67 |
| 30-day Volatility (annualised) | 39.0% |
| Price vs SMA 50 | -17.0% |
| Price vs SMA 200 | -11.4% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $25.42 | |
| 2026-01 | $26.00 | +2.3% |
| 2026-02 | $27.73 | +6.7% |
| 2026-03 | $24.84 | -10.4% |
| 2026-04 | $27.15 | +9.3% |
| 2026-05 | $33.30 | +22.7% |
| 2026-06 | $38.53 | +15.7% |
| 2026-07 | $38.62 | +0.2% |
| 2026-08 | $40.82 | +5.7% |
| 2026-09 | $33.78 | -17.2% |
| 2026-10 | $29.17 | -13.6% |
| 2026-11 | $28.41 | -2.6% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-09 | $-0.74 | $7M |
| 2026-08-06 | $-0.63 | $7M |
| 2026-05-20 | $-0.59 | |
| 2026-02-06 | $-0.72 | $6M |
| 2025-11-10 | $-0.72 | |
| 2025-08-11 | $-0.69 | |
| 2025-05-29 | $-0.71 | |
Price
| Price | $28.41 (closing price, November 2, 2026) |
| Market Cap | $5.9B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 7.94 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 7.27 |
| Piotroski F-Score | 1 |
| Altman Z-Score | 22.57 |